Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Gaurav Jain
Period: Reporting periods mapped to calendar 2024 Q4 – 2025 Q2 (3 quarters).
- Questions
- 16on tracked calls
- Challenge rate
- 38%6 of 16 questions
- Companies
- 3questioned at least once
- Reporting periods
- 3with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 16 of 16 questions from 3 companies
MOAltria9 questions · 3 reporting periods · 4 of 9 challenging
Calendar 2025 Q2
if I assume full excise tax, full MSA, then it is hard to conclude that there will be any EBIT left unless you are claiming this double duty drawback
Show response
Billy firmly separated Basic strategy from duty drawback. Drawback is about international manufacturing relationships. Basic is about targeted RGM analytics in price-sensitive stores.
is it that this reduction in disposable e-cigarette is helping the cigarette industry more than it has helped in the pod-based industry
Show response
Billy noted enforcement benefits both cigarettes and pods. Pushed for FDA to authorize more products since consumers have shown willingness to move to smoke-free.
do you think there are some of these international markets now where you can have an NGP only business and make it profitable
Show response
Billy confirmed belief in profitable international NGP business. Already have nicotine pouch distribution in Nordics and UK. Will be disciplined in expansion.
Calendar 2025 Q1
is it that you will just exit the market or because that doesn't seem to be a viable strategy long term
Show response
Billy confirmed e-vapor participation is essential long-term. Teams are incorporating consumer-preferred traits from disposables into NJOY pipeline. Close to resolving all four patent workarounds.
you have repositioned it down almost to the price of Lucky Strike. So and how you know
Show response
Billy framed Basic repositioning as historical pattern of rotating discount brands. Tests showed Basic effectively captured consumers unable to keep up with price increases.
do you think there is a risk to ON!'s trajectory as we go into the second half of the year
Show response
Management acknowledged growth rate will naturally slow as base grows and competition increases. Highlighted on! PLUS pipeline as key differentiator.
Calendar 2024 Q4
isn't that a market you also want to participate in not only on the nicotine pouch side but also on the e-cigarette side
Show response
Billy acknowledged synthetic nicotine has moved up on their radar as FDA applies enforcement discretion rather than outright banning.
on! pricing was up nicely in Q4. And despite that, the volume growth remains impressive
Show response
Management credited improved promotional analytics for sustaining growth while raising prices. Highlighted 40%+ consumer loyalty increase as evidence of brand strength.
you want to maximize profitability in cigarettes. But is there, like, larger share losses or worse
Show response
Billy framed share losses as cyclical consumer behavior during economic pressure, noting illicit vape distribution is also bleeding into cigarette-like white-label products.
PMPhilip Morris International5 questions · 2 reporting periods · 2 of 5 challenging
Calendar 2025 Q2
how should one read it that your expectations for future growth They were higher earlier, and now they are lower
Show response
Emmanuel dismissed significance of the 10-20M can shortfall in restocking, redirecting to ZYN's 36% offtake growth in June and 37%+ in early July as the key datapoint for demand health.
what exactly are the proposals in terms of different tax rates on NGP products
Show response
Emmanuel declined to speculate on the evolving EU proposal, noting the process will require unanimous approval and could take two years. Highlighted positive differentiation for smoke-free and disappointment on lacking illicit trade measures.
Calendar 2024 Q4
Could you just talk about that ELTA, what the product is, and then you think we can see it in the market?
Show response
Jacek expressed frustration with the 5-year FDA review timeline, hoped the new administration would accelerate processing, and emphasized need for legal market alternatives to combat illicit trade.
How do you control retail price? And is there a way for you to as supply normalizes, to reduce retail price
Show response
Jacek indicated retail pricing will normalize naturally as supply catches up, acknowledging retailers face challenges but expressing confidence in the trajectory.
the volumes have decelerated to mid teens growth. And your guidance is for thirty four percent to forty one percent growth
Show response
Jacek highlighted growing ZYN velocities in recent weeks, noting scanner data is difficult to read in a supply-constrained environment, and Q4 showed first significant sequential quarter-on-quarter growth.
SWSmurfit WestRock2 questions · 1 reporting period · 0 of 2 challenging
Calendar 2025 Q1
the Chinese container bold importers who are no longer importing from U.S., they are shifting some of their demand to LatAm. Is this something that you are noticing
Show response
Tony noted competitors focused on US-to-China exports are taking downtime. SW does no significant China exports but does export to LatAm with longstanding customer relationships. Chinese trade disruption seen as net positive for SW.
if we indeed get into weaker macro cycle and there is some opportunity which is too good to pass, would you consider it
Show response
Tony firmly stated focus is on deleveraging to 2.0x, with only smaller bolt-on acquisitions considered. Still much integration work to do across accounting, reporting, operations before any larger M&A. Not doing anything 'off the pitch.'
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| MO Altria | 9 | 44%4 of 9 questions |
| PM Philip Morris International | 5 | 40%2 of 5 questions |
| SW Smurfit WestRock | 2 | —Rate withheld: fewer than 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 6 | 33%2 of 6 questions | 2 |
| 2025 Q1 | 5 | 40%2 of 5 questions | 2 |
| 2025 Q2 | 5 | 40%2 of 5 questions | 2 |
- 2024 Q46 questions · challenge rate 33% (2 of 6 questions) · 2 companies
- 2025 Q15 questions · challenge rate 40% (2 of 5 questions) · 2 companies
- 2025 Q25 questions · challenge rate 40% (2 of 5 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Competitive Dynamics7
- Demand5
- Pricing4
- Regulation Policy4
- Product Launch4
- Supply Chain3
- Geographic Expansion1
- Trade Tariffs1
- Capital Allocation1
- M&A1